22 related articles for article (PubMed ID: 9620027)
1. Establishment of Patient-Derived Organoids Using Ascitic or Pleural Fluid from Cancer Patients.
Choi W; Kim YH; Woo SM; Yu Y; Lee MR; Lee WJ; Chun JW; Sim SH; Chae H; Shim H; Lee KS; Kong SY
Cancer Res Treat; 2023 Oct; 55(4):1077-1086. PubMed ID: 37309112
[TBL] [Abstract][Full Text] [Related]
2. Effect of sodium stibogluconate in recruiting and awakening immune cells in the pleural fluid of pancreatic cancer: preparation for immunotherapy.
Yu B; Jing P; Gao F; Zhang P; Zheng G; Zhang X
Front Immunol; 2023; 14():1315468. PubMed ID: 38313432
[TBL] [Abstract][Full Text] [Related]
3. Uncommon but valuable for diagnosis: Green deposits on peritoneal fluid cytospins.
Lesesve JF; GĂ©rard D; Burgevin A
Clin Case Rep; 2021 Mar; 9(3):1553-1555. PubMed ID: 33768887
[TBL] [Abstract][Full Text] [Related]
4. The prognostic impact of peritoneal tumour DNA in gastrointestinal and gynaecological malignancies: a systematic review.
Allan Z; Witts S; Tie J; Tebbutt N; Clemons NJ; Liu DS
Br J Cancer; 2023 Nov; 129(11):1717-1726. PubMed ID: 37700064
[TBL] [Abstract][Full Text] [Related]
5. K-ras point mutations in the supernatants of pancreatic juice and bile are reliable for diagnosis of pancreas and biliary tract carcinomas complementary to cytologic examination.
Yamashita K; Kida Y; Shinoda H; Kida M; Okayasu I
Jpn J Cancer Res; 1999 Feb; 90(2):240-8. PubMed ID: 10189896
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation.
Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N
J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567
[TBL] [Abstract][Full Text] [Related]
7. Application of the p53 and K-ras gene mutation patterns for cytologic diagnosis of recurrent lung carcinomas.
Dai Y; Morishita Y; Mase K; Sato N; Akaogi E; Mitsui T; Noguchi M
Cancer; 2000 Aug; 90(4):258-63. PubMed ID: 10966568
[TBL] [Abstract][Full Text] [Related]
8. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.
Stork P; Loda M; Bosari S; Wiley B; Poppenhusen K; Wolfe H
Oncogene; 1991 May; 6(5):857-62. PubMed ID: 1646989
[TBL] [Abstract][Full Text] [Related]
9. Ras gene activation in malignant cells of human ovarian carcinoma peritoneal fluids.
Dokianakis DN; Varras MN; Papaefthimiou M; Apostolopoulou J; Simiakaki H; Diakomanolis E; Spandidos DA
Clin Exp Metastasis; 1999 Jun; 17(4):293-7. PubMed ID: 10545015
[TBL] [Abstract][Full Text] [Related]
10. Detection of K-ras point mutations in the supernatants of peritoneal and pleural effusions for diagnosis complementary to cytologic examination.
Yamashita K; Kuba T; Shinoda H; Takahashi E; Okayasu I
Am J Clin Pathol; 1998 Jun; 109(6):704-11. PubMed ID: 9620027
[TBL] [Abstract][Full Text] [Related]
11. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.
Minamoto T; Mai M; Ronai Z
Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118
[TBL] [Abstract][Full Text] [Related]
12. Detection of short stature homeobox 2 and RAS-associated domain family 1 subtype A DNA methylation in interventional pulmonology.
Wu J; Li P
World J Clin Cases; 2021 Jul; 9(20):5391-5397. PubMed ID: 34307592
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]